Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Fernandez

Showing results (571-580 of 645) with videos related to

Pageof 65
Sort By:
The Clinical Neuropsychologist|March 17, 2007
Deep brain stimulation and the role of the neuropsychologistMichael S Okun, Ramon L Rodriguez, Ania Mikos, et al.
Neurology|July 14, 2004
Development and initial validation of a screening tool for Parkinson disease surgical candidatesM S Okun, H H Fernandez, O Pedraza, et al.
Frontiers in Neurology|March 14, 2022
Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension StudyRobert A Hauser, Hadas Barkay, Hubert H Fernandez, et al.
Cell|May 22, 2003
Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1Hung-Kai Chen, Pedro Fernandez-Funez, Summer F Acevedo, et al.
Journal of Neurosurgery|September 21, 2010
A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohortHoutan A Taba, Samuel S Wu, Kelly D Foote, et al.
Neurosurgery|August 22, 2019
Factors Associated With Postoperative Confusion and Prolonged Hospital Stay Following Deep Brain Stimulation Surgery for Parkinson DiseaseHesham Abboud, Gencer Genc, Saira Saad, et al.
Human Reproduction (Oxford, England)|June 24, 2024
Evaluating the safety of high-intensity focused ultrasound treatment for rectal endometriosis: results from a French prospective multicentre study including 60 patientsG Dubernard, E Maissiat, G Legendre, et al.
Parkinsonism & Related Disorders|July 27, 2020
Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosisClive G Ballard, David L Kreitzman, Stuart Isaacson, et al.
The Lancet. Neurology|July 15, 2026
Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trialHubert H Fernandez, Perminder Bhatia, Leslie Cloud, et al.
Transplantation|January 15, 1997
High-dose donor bone marrow infusions to enhance allograft survival: the effect of timingC Ricordi, T Karatzas, J Nery, et al.
Pageof 65

Showing results (571-580 of 645) with videos related to

Sort By:
Pageof 65
The Clinical Neuropsychologist|March 17, 2007
Deep brain stimulation and the role of the neuropsychologistMichael S Okun, Ramon L Rodriguez, Ania Mikos, et al.
Neurology|July 14, 2004
Development and initial validation of a screening tool for Parkinson disease surgical candidatesM S Okun, H H Fernandez, O Pedraza, et al.
Frontiers in Neurology|March 14, 2022
Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension StudyRobert A Hauser, Hadas Barkay, Hubert H Fernandez, et al.
Cell|May 22, 2003
Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1Hung-Kai Chen, Pedro Fernandez-Funez, Summer F Acevedo, et al.
Journal of Neurosurgery|September 21, 2010
A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohortHoutan A Taba, Samuel S Wu, Kelly D Foote, et al.
Neurosurgery|August 22, 2019
Factors Associated With Postoperative Confusion and Prolonged Hospital Stay Following Deep Brain Stimulation Surgery for Parkinson DiseaseHesham Abboud, Gencer Genc, Saira Saad, et al.
Human Reproduction (Oxford, England)|June 24, 2024
Evaluating the safety of high-intensity focused ultrasound treatment for rectal endometriosis: results from a French prospective multicentre study including 60 patientsG Dubernard, E Maissiat, G Legendre, et al.
Parkinsonism & Related Disorders|July 27, 2020
Long-term evaluation of open-label pimavanserin safety and tolerability in Parkinson's disease psychosisClive G Ballard, David L Kreitzman, Stuart Isaacson, et al.
The Lancet. Neurology|July 15, 2026
Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trialHubert H Fernandez, Perminder Bhatia, Leslie Cloud, et al.
Transplantation|January 15, 1997
High-dose donor bone marrow infusions to enhance allograft survival: the effect of timingC Ricordi, T Karatzas, J Nery, et al.
Pageof 65